MA S777

Prohibits health insurers from requiring patients to transport specialty medications from a pharmacy to a healthcare provider for administration, and from mandating home infusion or external infusion sites outside a patient's provider office

Requires insurers to provide at least 60 days' notice before implementing specialty pharmacy distribution requirements, along with expedited exception processes when providers certify patient safety concerns

Mandates that specialty pharmacies meet specific standards including same-day delivery, 24/7 pharmacist/nurse access, cold chain logistics for temperature control, national accreditation, and formal agreements with receiving hospitals

Exempts certain medications from specialty pharmacy distribution requirements: those requiring sterile compounding, patient-specific dosing based on same-day lab results, and federally controlled substances

Requires site-neutral payment to healthcare providers administering specialty medications, including reimbursement for intake, storage, and disposal costs; applies to Group Insurance Commission, Medicaid, commercial insurers, HMOs, and Health Connector plans